AJP - GI Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 292: G165-G172, 2007. First published July 13, 2006; doi:10.1152/ajpgi.00152.2006
0193-1857/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/G165    most recent
00152.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Melgar, S.
Right arrow Articles by Bohlooly-Y, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melgar, S.
Right arrow Articles by Bohlooly-Y, M.

INFLAMMATION/IMMUNITY/MEDIATORS

Mice with experimental colitis show an altered metabolism with decreased metabolic rate

Silvia Melgar,1 Mikael Bjursell,3,4 Anna-Karin Gerdin,3 Lennart Svensson,2 Erik Michaëlsson,1 and Mohammad Bohlooly-Y3

1Department of Integrative Pharmacology, Gastrointestinal Biology, 2Department of Molecular Pharmacology, and 3AstraZeneca Transgenics and Comparative Genomics Centre, AstraZeneca Research and Development, Mölndal; and 4Department of Physiology/Endocrinology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden

Submitted 6 April 2006 ; accepted in final form 5 July 2006

Patients with inflammatory bowel disease (IBD) suffer from body weight loss, malnutrition, and several other metabolic alterations affecting their quality of life. The aim of this study was to investigate the metabolic changes that may occur during acute and chronic colonic inflammation induced by dextran sulfate sodium (DSS) in mice. Clinical symptoms and inflammatory markers revealed the presence of an ongoing inflammatory response in the DSS-treated mice. Mice with acute inflammation had decreased body weight, respiratory exchange ratios (RER), food intake, and body fat content. Mice with chronic inflammation had decreased nutrient uptake, body fat content, locomotor activity, metabolic rates, and bone mineral density. Despite this, the body weight, food and water intake, lean mass, and RER of these mice returned to values similar to those in healthy controls. Thus, murine experimental colitis is associated with significant metabolic alterations similar to IBD patients. Our data show that the metabolic responses during acute and chronic inflammation are different, although the metabolic rate is reduced in both phases. These observations suggest compensatory metabolic alterations in chronic colitis resulting in a healthy appearance despite gross colon pathology.

dual-energy X-ray absorptiometry; dextran sulfate sodium; colon inflammation; respiratory exchange ratio



Address for reprint requests and other correspondence: S. Melgar, Dept. of Integrative Pharmacology, GI Biology, AstraZeneca R&D, Pepparedsleden 1, Mölndal SE-431 81, Sweden (e-mail: silvia.melgar{at}astrazeneca.com)




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Harris, P. Senagore, V. B. Young, and L. R. McCabe
Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice
Am J Physiol Gastrointest Liver Physiol, May 1, 2009; 296(5): G1020 - G1029.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.